Michelle Petri, MD MPH

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Astrazeneca
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Atara Biosciences
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    10/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Aurinia
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Autolus
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Bain Capital
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Baobab Therapeutics
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    05/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Bavarian Nordic
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Beeline
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Biocryst
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    04/22/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Biogen
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026

Pages

Return to 2026 Florida Society of Rheumatology Annual Meeting